LIN28B and hepatocellular carcinoma: In fact, enhanced aerobic glycolysis has been observed in hepatocellular carcinomas overexpressing LIN28B, where LIN28B acts by targeting the metabolic enzyme PDH kinase 1 (PDK1) [16].